Patrick Gladding

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

Combination Therapy using Co-encapsulated Resveratrol and Paclitaxel in Liposomes for Drug Resistance Reversal in Breast Cancer Cells in vivo

American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee

Clopidogrel with or without Omeprazole in Coronary Artery Disease

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning”

Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysis

Perioperative Management of Antithrombotic Therapy

Oral Anticoagulant Therapy

Thromboses itératives de pontages artériels et cancer : à propos de trois cas

Antiplatelet Drugs

Heart failure with mid-range or mildly reduced ejection fraction

Nano based drug delivery systems: recent developments and future prospects

Sudden cardiac death in children (1-18 years): symptoms and causes of death in a nationwide setting

CYP2C9 Genotype-guided Warfarin Prescribing Enhances the Efficacy and Safety of Anticoagulation: A Prospective Randomized Controlled Study

ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use

Natural product-based nanoformulations for cancer therapy: Opportunities and challenges

The Year in Non–ST-Segment Elevation Acute Coronary Syndrome

Management of Patients With Ulcer Bleeding

The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition

Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel

Cardiac Channel Molecular Autopsy: Insights From 173 Consecutive Cases of Autopsy-Negative Sudden Unexplained Death Referred for Postmortem Genetic Testing

Immediate and Midterm Results following Treatment of Unruptured Intracranial Aneurysms with the Pipeline Embolization Device

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)

Deep learning for cardiac computer-aided diagnosis: benefits, issues & solutions

The effect of CYP2C19 gene polymorphisms on the pharmacokinetics and pharmacodynamics of prasugrel 5-mg, prasugrel 10-mg and clopidogrel 75-mg in patients with coronary artery disease

Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion

2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines

Multistage Microfluidic Platform for the Continuous Synthesis of III–V Core/Shell Quantum Dots

The interaction of ibuprofen and diclofenac with aspirin in healthy volunteers

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

Endovascular Treatment of Intracranial Aneurysms With Flow Diverters

2012 Update to The Society of Thoracic Surgeons Guideline on Use of Antiplatelet Drugs in Patients Having Cardiac and Noncardiac Operations

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel

Multistage Microfluidic Platform for the Continuous Synthesis of III–V Core/Shell Quantum Dots

ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning”

A Survey of Deep Learning and Its Applications: A New Paradigm to Machine Learning

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use

Global burden of heart failure: a comprehensive and updated review of epidemiology

ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use

New Generation Cadmium-Free Quantum Dots for Biophotonics and Nanomedicine

Pharmacogenetic Testing for Clopidogrel Using the Rapid INFINITI Analyzer

Antiplatelet drug nonresponsiveness

Late Drug-eluting Stent Thrombosis and Erythropoietin: Cause and Effect?

The Antiplatelet Effect of Six Non-Steroidal Anti-Inflammatory Drugs and Their Pharmacodynamic Interaction With Aspirin in Healthy Volunteers

The Antiplatelet Effect of Higher Loading and Maintenance Dose Regimens of Clopidogrel

Posthumous diagnosis of long QT syndrome from neonatal screening cards

The Pharmacogenetics and Pharmacodynamics of Clopidogrel Response

Routinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie?

Plasmonic gold and luminescent silicon nanoplatforms for multimode imaging of cancer cells

Open Access Integrated Therapeutic and Diagnostic Platforms for Personalized Cardiovascular Medicine